Three Georgia companies and their principals have been banned from continuing their "bogus claims" that their stem cell ...
D Molecular Therapeutics (NASDAQ:FDMT) and the U.S. FDA have reached agreement on a phase 3 trial design for diabetic macular ...
A whole grain breaded broccoli nugget product has been recalled due to fears that it may contain metal.
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
Johnson & Johnson JNJ announced that the FDA has accepted its regulatory filing seeking the FDA’s approval for nipocalimab, ...
The Government Accountability Office found a significant drop-off in inspections during the pandemic. The FDA says inspector understaffing has hampered efforts to meet its targets. Separately, the VA ...
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
Following the FDA’s release of a guidance requesting more diversity in pulse oximeter testing, the number of clearance ...
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
Basic public health protections help augment our national security protections,” particularly when it comes to emerging ...
Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback